Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04735705Not ApplicableCompleted

Clinical Investigation To Evaluate Cerviron Ovules® in Symptomatic Vaginitis

Role: lead

NCT05654610Completed

Real-world Evidence Study on the Performance and Safety of Halova Ovules

Role: lead

NCT05652959Completed

Real-world Performance and Safety of Cerviron® in the Treatment of Vaginitis

Role: lead

NCT04735718Not ApplicableCompleted

Clinical Investigation To Evaluate Cerviron Ovules® in Cervix Lesions Postoperative Care

Role: lead

NCT05668806Completed

RWE Study in the Treatment of Cervical Lesions of Various Etiology

Role: lead

All 5 trials loaded